Becton Dickinson

+$1.16 (+0.5%)
Closing price May 20, 2022
Additional top analyst upgrades and downgrades for Friday included Becton Dickinson, Booz Allen Hamilton, Cummins, Datadog, Lennar, RealReal, Stitch Fix, StoneCo and United Airlines.
Thursday's premarket winners and losers included Meta Platforms, PayPal, Spotify, T-Mobile and Twitter.
Thursday’s top analyst upgrades and downgrades included AutoZone, Charter Communications, Edwards Lifesciences, FuboTV, MFA Financial, Phillips 66, Southwest Airlines, Stitch Fix, TechnicFMC and...
Tuesday's top analyst upgrades and downgrades included Albertsons, Charles Schwab, Colgate-Palmolive, CyberArk Software, Deckers Outdoor, Dow, Lordstown Motors, Nike, Procter & Gamble and Tesla.
Friday’s top analyst upgrades and downgrades included BP, Cloudflare, Expedia, FireEye, Marathon Oil, Moderna, Pinduoduo, Vertex Pharmaceuticals and ViacomCBS.
BofA Securities feels these four top medtech companies are all poised for potential positive news and developments in the near future. These stocks could be good additions to growth portfolios...
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
With the focus on health care expected to remain center stage for 2020, these Raymond James top health care stock picks all make sense now.
Monday's top analyst upgrades and downgrades included, Canopy Growth, CarMax, Chipotle Mexican Grill, Geron, Hess, Inogen, Occidental Petroleum, Snap, Teva Pharmaceutical, Vail Resorts and...
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
Co-Diagnostics has been the toast of Wall Street after it went from penny stock status to a revered coronavirus testing stock.
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.